Amanote Research
Register
Sign In
Treating Renal Anaemia With Erythropoietin
BMJ
doi 10.1136/bmj.300.6728.879-a
Full Text
Open PDF
Abstract
Available in
full text
Date
March 31, 1990
Authors
R. Gabriel
Publisher
BMJ
Related search
Treating Renal Anaemia With Recombinant Human Erythropoietin: Practical Guidelines and a Clinical Algorithm.
BMJ
Monitoring Erythropoietin Therapy for Anaemia of Chronic Renal Failure by Serum Erythropoietin Assays
Annals of Clinical Biochemistry
Medicine
Clinical Biochemistry
Non-Cardiac Benefits of Human Recombinant Erythropoietin in End Stage Renal Failure and Anaemia.
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
Erythropoietin Response to Anaemia in Heart Failure
European Journal of Preventive Cardiology
Epidemiology
Cardiovascular Medicine
Cardiology
82 Recombinant Human Erythropoietin in the Treatment of Anaemia in Children With End-Stage Renal Failure Maintained by Haemodialysis
Pediatric Research
Child Health
Pediatrics
Perinatology
Maintenance Therapy With Erythropoietin for Renal Anemia
Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
Treating Anemia Associated With Chronic Renal Failure With Erythropoiesis Stimulators: Recombinant Human Erythropoietin Might Be the Best Among the Available Choices
Medical Hypotheses
Medicine
Treating Sickle Cell Anaemia: The TWiTCH Trial
The Lancet
Medicine
Response of Anaemia in Rheumatoid Arthritis to Treatment With Subcutaneous Recombinant Human Erythropoietin.
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
